Physician profile
Sandeep Chandra
NPI 1063453876
$3,197.90
in general payments reported to CMS, 2019-2025
16 companies · $724 in 2025
The $724 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $142 · 2021: $406 · 2022: $747 · 2023: $327 · 2024: $668 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,719.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,401.29 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $474.08 | 2019-2025 | |
| Glaxosmithkline, LLC. | $276.44 | 2020-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $241.92 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Baxter Healthcare | $198.88 | 2022 | |
| Janssen Pharmaceuticals, INC | $151.27 | 2022-2024 | Xarelto |
| Boston Scientific Corporation | $141.50 | 2022 | |
| Inari Medical, INC. | $122.16 | 2021 | |
| Amgen INC. | $55.01 | 2025 | Repatha, Otezla |
| Mannkind Corporation | $25.78 | 2025 | |
| Abbvie INC. | $21.31 | 2025 | |
| Abbott Laboratories | $21.25 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.68 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.55 | 2022 | |
| Merck Sharp & Dohme LLC | $16.42 | 2023 | Verquvo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $15.36 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Chandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.